Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Today's Low | Today's High | |
---|---|---|
657.00 657.00 |
| 682.40 683.30 |
52 Week Low | 52 Week High | |
---|---|---|
399.55 (14-Mar-2024) 380.65 (14-Mar-2024) |
| 721.70 (29-Aug-2024) 721.00 (29-Aug-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
0 | 2,022 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Ask Price | Quantity |
---|---|
679.60 | 2,022.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 2,022 |
Market Cap: | 61.63 Cr |
PE Ratio (TTM): | 29.84 |
PB Ratio: | 3.60 |
Industry P/E: | 26.13 |
Debt to Equity: | - |
ROE: | 12.08 |
EPS (TTM): | 22.75 |
Book Value: | 0.00 |
Face Value: | 5.00 |
Jun, 2023 | Mar, 2023 | Sep, 2023 | Jun, 2023 | Jun, 2023 | |
---|---|---|---|---|---|
Revenue | 116.56 Cr | 12.05 Cr | 12.43 Cr | 12.07 Cr | 358.14 Cr |
Profit | 5.17 Cr | 137.70 Cr | -0.99 Cr | 0.46 Cr | 47.63 Cr |
Expense | 110.05 Cr | 13.21 Cr | 12.96 Cr | 11.61 Cr | 300.87 Cr |
Comprehensive income | 5.17 Cr | 100.82 Cr | -0.99 Cr | 0.46 Cr | 48.80 Cr |
EPS | 0.93 | 4.52 | -0.03 | 0.01 | 5.26 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Aarti Pharmalabs Limited | Jan, 2023 Jan, 2023 | Pharmaceuticals Pharmaceuticals | AARTIPHARM AARTIPHARM |
Promoters | |
---|---|
46.30% |
Public | |
---|---|
53.70% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
45.98% |
Public | |
---|---|
54.02% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
45.98% |
Public | |
---|---|
54.02% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
44.16% |
Public | |
---|---|
55.84% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 657.00 on the NSE (National Stock Exchange) to a maximum of 682.40. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 657.00 to a high of 683.30.
The stock's performance over the past 52 weeks reveals a low of 399.55 (occurred on 14-Mar-2024) and a high of 721.70 (achieved on 29-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 380.65 (on 14-Mar-2024), and the 52-week high is 721.00 (on 29-Aug-2024).
The stock's performance over the past 52 weeks reveals a low of 399.55 (occurred on 14-Mar-2024) and a high of 721.70 (achieved on 29-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 380.65 (on 14-Mar-2024), and the 52-week high is 721.00 (on 29-Aug-2024).
The total volume is 3, and the total traded value is 21.95 ( Lakhs).
The upper circuit limit is 789.15, and the lower circuit limit is 526.15.
The market cap is 61.63 Cr, and the PE ratio (TTM) is 26.13.
ROE is 12.08, EPS is 22.75, book value is not available
In Jun 2023, Revenue is 1165605000.00, and Profit is 51674000.00. In Mar 2023, Revenue is 120541000.00, and Profit is 1377014000.00.
The company, Aarti Pharmalabs Limited, was listed in Jan 2023 and belongs to the Pharmaceuticals industry. Its NSE symbol is AARTIPHARM.
As of latest available update, promoters hold 46.30%, the public holds 53.70%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.